Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesRenal cell carcinoma with an emphasis on drug therapy of advanced disease, part 2
American Journal of Health-System Pharmacy, 09/14/09
Cersosimo RJ – The options available for the management of advanced RCC have expanded considerably in the past five years with the advent of molecularly targeted therapies.
Related Articles
Chromosomal abnormalities of clear cell renal cell carcinoma: Frequent gain of chromosome 7
Pathology International, 11/19/09
Relevance Score: 89%
Potential use of circulating endothelial cells as a biomarker of renal cell carcinoma
Urologic Oncology: Seminars and Original Investigations, 11/19/09
Relevance Score: 84%
Population-based survey of cancer risks in chromosome 3 translocation carriers
Genes, Chromosomes and Cancer, 10/28/09
Relevance Score: 84%
Apolipoprotein E/C1 Locus Variants Modify Renal Cell Carcinoma Risk
Cancer Research, 10/20/09
Relevance Score: 84%
Surgical Treatment of Renal Cell Carcinoma in the Immunocompromised Transplant Patient
Urology, 10/12/09
Relevance Score: 84%
Today in Chemotherapy/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Expert Opinion on Investigational Drugs, 12/16/09
Plerixafor for Stem Cell Mobilization in Patients with Non-Hodgkin's Lymphoma and Multiple Myeloma
Annals of Pharmacotherapy, 12/16/09
Clinically-Staged T3N0 Rectal Cancer: Is Preoperative Chemoradiotherapy the Optimal Treatment
Annals of Surgical Oncology, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor